PT83530B - Processo de preparacao de derivados da piridona, em especial derivados fenilicos - Google Patents

Processo de preparacao de derivados da piridona, em especial derivados fenilicos

Info

Publication number
PT83530B
PT83530B PT83530A PT8353086A PT83530B PT 83530 B PT83530 B PT 83530B PT 83530 A PT83530 A PT 83530A PT 8353086 A PT8353086 A PT 8353086A PT 83530 B PT83530 B PT 83530B
Authority
PT
Portugal
Prior art keywords
derivatives
phenyler
preparation process
pyridone
pyridone derivatives
Prior art date
Application number
PT83530A
Other languages
English (en)
Other versions
PT83530A (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858525654A external-priority patent/GB8525654D0/en
Priority claimed from GB868601667A external-priority patent/GB8601667D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT83530A publication Critical patent/PT83530A/pt
Publication of PT83530B publication Critical patent/PT83530B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT83530A 1985-10-17 1986-10-13 Processo de preparacao de derivados da piridona, em especial derivados fenilicos PT83530B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858525654A GB8525654D0 (en) 1985-10-17 1985-10-17 Chemical compounds
GB868601667A GB8601667D0 (en) 1986-01-23 1986-01-23 Chemical compounds

Publications (2)

Publication Number Publication Date
PT83530A PT83530A (en) 1986-11-01
PT83530B true PT83530B (pt) 1989-05-31

Family

ID=26289898

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83530A PT83530B (pt) 1985-10-17 1986-10-13 Processo de preparacao de derivados da piridona, em especial derivados fenilicos

Country Status (16)

Country Link
US (2) US4906628A (pt)
EP (1) EP0220044B1 (pt)
CN (1) CN1009092B (pt)
AU (1) AU586042B2 (pt)
DE (1) DE3677316D1 (pt)
DK (1) DK491186A (pt)
ES (1) ES2031821T3 (pt)
FI (1) FI864193A7 (pt)
GR (1) GR3001555T3 (pt)
HU (1) HU196788B (pt)
IL (1) IL80296A (pt)
NO (1) NO864126L (pt)
NZ (1) NZ217931A (pt)
PH (1) PH22428A (pt)
PT (1) PT83530B (pt)
ZW (1) ZW20586A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962110A (en) * 1985-03-12 1990-10-09 Smith Kline & French Laboratories Limited Pyridazinone derivatives
GB8610369D0 (en) * 1986-04-28 1986-06-04 Smith Kline French Lab Heterocyclic compounds
GB8621864D0 (en) * 1986-09-11 1986-10-15 Smith Kline French Lab Chemical process
GB8901836D0 (en) * 1989-01-27 1989-03-15 Sobio Lab Compounds
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
HU208124B (en) * 1990-04-25 1993-08-30 Nissan Chemical Ind Ltd Process for producing pyridazinone derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
ATE180475T1 (de) * 1990-09-21 1999-06-15 Rohm & Haas Dihydropyridazinone und pyridazinone als fungizide
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) * 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
PL1951227T3 (pl) * 2005-11-14 2017-09-29 Boehringer Ingelheim Vetmedica Gmbh Zastosowania pimobendanu do leczenia bezobjawowej(utajonej) niewydolności serca
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8664252B2 (en) 2008-11-25 2014-03-04 Boehringer Ingelheim Vetmedica Gmbh Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
PL3021832T3 (pl) 2013-07-19 2021-08-23 Boehringer Ingelheim Vetmedica Gmbh Konserwowana ciekła wodna kompozycja farmaceutyczna zawierająca eteryfikowane pochodne cyklodekstryny
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
BR122019024673B1 (pt) 2013-12-04 2023-04-11 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
AU2020215088A1 (en) 2019-02-01 2021-07-22 Bayer Aktiengesellschaft 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
DE102021105255B4 (de) * 2021-03-04 2022-10-13 Festo Se & Co. Kg Vorrichtung mit über eine Verbindungsschnittstelle verbundenen Bauteilen und Verfahren zur Verbindung von Bauteilen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69407A (en) * 1982-08-23 1987-10-20 Warner Lambert Co 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
DE3600891A1 (de) * 1986-01-15 1987-07-16 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
CN1009092B (zh) 1990-08-08
EP0220044A3 (en) 1988-02-24
HUT41769A (en) 1987-05-28
NO864126D0 (no) 1986-10-16
PT83530A (en) 1986-11-01
FI864193A7 (fi) 1987-04-18
US5066653A (en) 1991-11-19
EP0220044B1 (en) 1991-01-30
ZW20586A1 (en) 1988-05-25
PH22428A (en) 1988-09-12
DE3677316D1 (de) 1991-03-07
AU6416686A (en) 1987-04-30
US4906628A (en) 1990-03-06
EP0220044A2 (en) 1987-04-29
ES2031821T3 (es) 1993-01-01
DK491186D0 (da) 1986-10-14
HU196788B (en) 1989-01-30
GR3001555T3 (en) 1992-11-23
FI864193A0 (fi) 1986-10-16
AU586042B2 (en) 1989-06-29
CN86106546A (zh) 1987-05-20
DK491186A (da) 1987-04-18
NO864126L (no) 1987-04-21
IL80296A (en) 1990-06-10
NZ217931A (en) 1989-04-26

Similar Documents

Publication Publication Date Title
PT83530B (pt) Processo de preparacao de derivados da piridona, em especial derivados fenilicos
PT83608B (pt) Processo de preparacao de derivados da paroxetina
PT83643B (pt) Processo de preparacao de derivados de quinoleina
FI870582A7 (fi) Aminouretaaneja, niiden valmistusmenetelmä ja niiden käyttö
FI884947A7 (fi) Tetrahydro-furo- ja -tieno/2,3-c/pyridiinit, niiden käyttö lääkeaineina ja menetelmä niiden valmistamiseksi
BR8602293A (pt) Processo catalitico de preparacao 1,4-cispolibutadieno
SE8600668D0 (sv) 4-substituted androstendione derivatives and process for their preparation
BR8605210A (pt) Processos para a preparacao de piridina-2,3-dicarboxilatos substituidos e di-substituidos e processo para a preparacao de nicotinatos substituidos
BR8606968A (pt) Perfluoropolieteres e processo de preparacao dos mesmos
PT83451B (pt) Processo para a preparacao de derivados de quinolina, benzotiazole e seus analogos
PT91098A (pt) Processo de preparacao de derivados de (aza)naftalenossultame
FI860878A7 (fi) Aminohappojohdokset ja menetelmä niiden valmistamiseksi.
FI861987L (fi) Piperidylideeni dihydrodibentso/a,d/syklohepteenien ja niiden atsajohdosten valmistusmenetelmä
BR8603592A (pt) Derivados de piridazinona,processo para sua preparacao,e composicoes inseticidas
FI892675A7 (fi) 2,6-dihalogeenipyridiini-3-karboksyylihappojohdannaiset ja niiden valmistus
DK47787D0 (da) Dihydropyridinderivatholdige retardpraeparater
FI860556A7 (fi) Uusia 1,8-naftyridiinijohdannaisia ja niiden valmistusmenetelmä.
PT81433B (pt) Processo de preparacao de comestico anti-rugas
DK9887A (da) Pyridinderivater
FI853698A7 (fi) Pyrimidiinijohdokset, menetelmä niiden valmistamiseksi ja näiden seokset.
PT92605A (pt) Processo de preparacao de derivados da 2-imino-6-polifluoroalcoxibenzotiazolina
DK46287A (da) Pyridinderivater
KR860005814A (ko) 1,6-나프티리딘-2(1h)-온 및 그의 제조방법
FI850266A7 (fi) Atsolyyliaryylialkanolijohdoksia, menetelmä niiden valmistamiseksi ja niiden käyttö.
MA20660A1 (fr) Derives de nitrofuranne, leur preparation et leur application

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940531